John Macka,
Raygan Murraya,
Kenedi Lynchb and
Netzahualcóyotl Arroyo-Currás*ac
aBiochemistry, Cellular and Molecular Biology Program, Johns Hopkins University School of Medicine, 316 Hunterian Building, 725 North Wolfe Street, Baltimore, MD 21205, USA. E-mail: netzarroyo@jhmi.edu; Tel: +1 443 287 4798
bAmgen Scholars Program, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD 21218, USA
cDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
First published on 29th May 2025
Correction for ‘3D-printed electrochemical cells for multi-point aptamer-based drug measurements’ by John Mack et al., Sens. Diagn., 2024, 3, 1533–1541, https://doi.org/10.1039/D4SD00192C.
The correct sequence for the tobramycin aptamer is given in the corrected Table 1 shown below, maintaining the original citation.
Name | Sequence |
---|---|
Tobramycin13 | 5′-GGG ACT TGG TTT AGG TAA TGA GTC CC-3′ |
Vancomycin1 | 5′-CGA GGG TAC CGC AAT AGT ACT TAT TGT TCG CCT ATT GTG GGT CGG-3′ |
L-Procaine14 | 5′-GGC GAC AAG GAA AAT CCT TCA ACG AAG GTG GGT GGC C-3′ |
Irinotecan11 | Proprietary (Aptamer Group, York, UK) |
We apologize for this error, which occurred because of a copy-paste mistake during finalizing the manuscript draft. This mistake does not impact the significance, interpretation, or conclusion of the results of this study. However, we believe it important to clarify for the sake of transparency and repeatability.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2025 |